| The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair H Lu, X Guo, X Meng, J Liu, C Allen, J Wray, JA Nickoloff, Z Shen Molecular and cellular biology, 2005 | 111 | 2005 |
| Recovery from DNA damage-induced G2 arrest requires actin-binding protein filamin-A/actin-binding protein 280 X Meng, Y Yuan, A Maestas, Z Shen Journal of Biological Chemistry 279 (7), 6098-6105, 2004 | 75 | 2004 |
| Drug resistance mediated by AEG-1/MTDH/LYRIC X Meng, KW Thiel, KK Leslie Advances in cancer research 120, 135-157, 2013 | 73 | 2013 |
| Synthetically lethal nanoparticles for treatment of endometrial cancer K Ebeid, X Meng, KW Thiel, AV Do, SM Geary, AS Morris, EL Pham, ... Nature nanotechnology 13 (1), 72-81, 2018 | 70 | 2018 |
| A mechanism for synergy with combined mTOR and PI3 kinase inhibitors S Yang, X Xiao, X Meng, KK Leslie PloS one 6 (10), e26343, 2011 | 64 | 2011 |
| Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment X Meng, P Brachova, S Yang, Z Xiong, Y Zhang, KW Thiel, KK Leslie PLoS One 6 (6), e20920, 2011 | 63 | 2011 |
| Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein X Meng, D Zhu, S Yang, X Wang, Z Xiong, Y Zhang, P Brachova, ... Journal of Biological Chemistry 287 (7), 4485-4491, 2012 | 62 | 2012 |
| Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers HD Reyes, KW Thiel, MJ Carlson, X Meng, S Yang, JM Stephan, ... Molecular diagnosis & therapy 18, 137-151, 2014 | 57 | 2014 |
| Correlation of MTDH/AEG-1 and HOTAIR expression with metastasis and response to treatment in sarcoma patients MM Milhem, T Knutson, S Yang, D Zhu, X Wang, KK Leslie, X Meng Journal of cancer science & therapy, 2011 | 55 | 2011 |
| BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage H Lu, J Yue, X Meng, JA Nickoloff, Z Shen Nucleic acids research 35 (21), 7160-7170, 2007 | 53 | 2007 |
| Genomic structure of the human BCCIP gene and its expression in cancer X Meng, J Liu, Z Shen Gene 302 (1-2), 139-146, 2003 | 52 | 2003 |
| AZD1775 increases sensitivity to olaparib and gemcitabine in cancer cells with p53 mutations X Meng, J Bi, Y Li, S Yang, Y Zhang, M Li, H Liu, Y Li, ME Mcdonald, ... Cancers 10 (5), 149, 2018 | 51 | 2018 |
| Roles of BCCIP in chromosome stability and cytokinesis X Meng, J Fan, Z Shen Oncogene 26 (43), 6253-6260, 2007 | 50 | 2007 |
| SETDB1 in cancer: overexpression and its therapeutic implications VJ Lazaro-Camp, K Salari, X Meng, S Yang American journal of cancer research 11 (5), 1803, 2021 | 48 | 2021 |
| Metadherin enhances vulnerability of cancer cells to ferroptosis J Bi, S Yang, L Li, Q Dai, N Borcherding, BA Wagner, GR Buettner, ... Cell death & disease 10 (10), 682, 2019 | 48 | 2019 |
| Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer S Yang, Y Jia, X Liu, C Winters, X Wang, Y Zhang, EJ Devor, AM Hovey, ... Oncotarget 5 (20), 9783, 2014 | 48 | 2014 |
| Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53 X Meng, LL Laidler, EA Kosmacek, S Yang, Z Xiong, D Zhu, X Wang, ... Gynecologic oncology 128 (3), 461-469, 2013 | 48 | 2013 |
| Epigenetic modification restores functional PR expression in endometrial cancer cells S Yang, X Xiao, Y Jia, X Liu, Y Zhang, X Wang, C J Winters, E J Devor, ... Current pharmaceutical design 20 (11), 1874-1880, 2014 | 46 | 2014 |
| Inhibition of G1 to S cell cycle progression by BCCIPb X Meng, J Liu, Z Shen Cell Cycle 3 (3), 341-346, 2004 | 44 | 2004 |
| Inverse relationship between progesterone receptor and Myc in endometrial cancer T Kavlashvili, Y Jia, D Dai, X Meng, KW Thiel, KK Leslie, S Yang PloS one 11 (2), e0148912, 2016 | 43 | 2016 |
